Butorphanol
Butorphanol is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Esketamine and Butorphanol for Post-Lobectomy Pain
Butorphanol in Pain Following Ablation for Hepatic Tumor
Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation
The Analgesic Effect of Butorphanol After Cesarean Section
Butorphanol Mitigate Emergence Agitation in Patients Undergoing Functional Endoscopic Sinus Surgery
Clinical Trials (8)
Esketamine and Butorphanol for Post-Lobectomy Pain
Butorphanol in Pain Following Ablation for Hepatic Tumor
Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation
The Analgesic Effect of Butorphanol After Cesarean Section
Butorphanol Mitigate Emergence Agitation in Patients Undergoing Functional Endoscopic Sinus Surgery
Using Preoperative Anxiety Score to Determine the Precise Dose of Butorphanol for Sedation
Using Preoperative Anxiety Score to Determine the Total Dose of Butorphanol for Sedation
Effect of Butorphanol Combined With Flurbiprofen Axetil on Preventing Hyperalgesia Induced by Remifentanil in Patients
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8